India’s BSE Sensex rose about 0.8% to 76,728 on Friday, recovering after four consecutive sessions of losses as expectations for a September U.S. Federal Reserve rate hike eased and improved risk appetite. Federal Reserve Governor Christopher Waller favored keeping rates unchanged if incoming data confirms that inflation pressures are easing. Gains were restrained by higher oil prices and tensions in the Middle East, with Brent crude near $96 a barrel and heading for its strongest weekly increase since mid-July. Investors also remained cautious about India’s new closing-auction mechanism, a process used to set end-of-day prices, after Sensex put premiums surged 400%-500% on Thursday when the indicative index briefly dropped 2.5%. Traders responded by reducing positions and increasing hedges. Gland Pharma attracted attention after reports said Fosun Pharma could sell as much as a 5% stake worth 22.8 billion rupees through a block deal. IFCI rose 5.2%, Angel One gained 5% and Reliance advanced 2.1%. Despite Friday’s rebound, the benchmark was down 0.7% week-to-date and was on course for a fourth consecutive weekly decline.